🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

62,31 USD

Máx. histórico

108,06

1030 días

Split 1:6 del 25/06/2013

Caída desde máximo

-42,34%

Rango 52 semanas

58,05 – 88,31

Variación hoy

+0,45%

Cierre anterior

62,03

Rango de hoy

62,05 – 64,37

Volumen hoy

1.699.286

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,37%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 10 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/01/2025 47,29 47,42 45,51 45,74 -2,66% 4,04% 998.300
16/01/2025 46,83 47,61 46,49 46,99 +0,26% 2,39% 792.100
15/01/2025 46,39 48,45 45,77 46,87 +3,63% 5,78% 1.174.300
14/01/2025 47,01 47,30 44,79 45,23 -3,17% 5,34% 1.388.800
13/01/2025 46,65 47,04 44,49 46,71 +0,19% 5,47% 1.288.500
10/01/2025 46,40 47,10 45,17 46,62 -1,58% 4,16% 1.758.100
08/01/2025 48,01 48,49 47,19 47,37 -2,35% 2,71% 904.200
07/01/2025 49,32 49,96 48,07 48,51 -1,38% 3,83% 1.266.000
06/01/2025 49,20 49,80 48,77 49,19 -0,34% 2,09% 761.900
03/01/2025 49,04 50,15 49,04 49,36 +0,88% 2,26% 1.007.700
02/01/2025 48,19 49,50 47,76 48,93 +4,02% 3,61% 865.700
31/12/2024 47,50 47,78 46,80 47,04 -0,23% 2,06% 797.900
30/12/2024 47,00 47,79 46,52 47,15 -0,44% 2,70% 1.043.200
27/12/2024 48,13 48,85 47,22 47,36 -2,43% 3,39% 902.000
26/12/2024 48,14 48,95 47,99 48,54 +0,02% 1,99% 942.100
24/12/2024 48,85 49,11 48,00 48,53 -0,86% 2,27% 319.000
23/12/2024 49,18 49,99 47,72 48,95 +0,16% 4,62% 1.198.300
20/12/2024 46,85 50,32 46,85 48,87 +4,56% 7,41% 3.805.200
19/12/2024 46,45 47,30 45,66 46,74 +0,82% 3,53% 1.377.400
18/12/2024 48,00 49,40 46,00 46,36 -2,97% 7,08% 1.587.100
17/12/2024 48,50 49,04 47,38 47,78 -2,53% 3,42% 1.372.400
16/12/2024 48,61 49,58 48,54 49,02 +0,76% 2,14% 758.200
13/12/2024 50,10 50,24 48,14 48,65 -3,16% 4,19% 1.432.100
12/12/2024 50,29 50,68 49,52 50,24 -0,91% 2,31% 1.153.400
11/12/2024 50,42 50,90 49,84 50,70 +0,30% 2,10% 650.900
10/12/2024 50,38 51,26 50,12 50,55 +0,10% 2,26% 703.000
09/12/2024 51,18 51,71 50,21 50,50 -0,90% 2,93% 881.200
06/12/2024 50,57 51,98 50,15 50,96 +1,11% 3,62% 580.800
05/12/2024 49,78 50,65 49,73 50,40 -0,08% 1,85% 832.500
04/12/2024 51,21 51,53 50,38 50,44 -2,08% 2,25% 1.043.300